Analysis on association between the polymorphisms in apolipoprotein E, interleukin-1α genes and Alzheimer's disease in Chengdu area

Chinese Journal of Medical Genetics

Volumn 21, Issue 2, 2004, Pages 176-178

  Tang, Mu Ni ^a   Zhang, Zhen Xin ^a   Han, Hai Ying ^c   Liu, Xie He ^d   Shen, Yan ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c Guangzhou Brain Hospital   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Apolipoprotein E; Interleukin 1

Indexed keywords

APOLIPOPROTEIN E; INTERLEUKIN 1ALPHA;

ALZHEIMER DISEASE; ARTICLE; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; HUMANS; INTERLEUKIN-1; POLYMORPHISM, GENETIC;

EID: 1942504336     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease. JAMA, 1997, 278: 1349-1356.
2. Etminan M, Gill S, Samii A. Effect of non-steroidal antiinflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ, 2003, 327: 128-132.
3. Mrak RE, Griffin WS. Interleukin-1 and the immunogenetics of Alzheimer's disease. J Neuropathol Exp Neurol, 2000, 59: 471-476.
4. Du Y, Dodel RC, Eastwood BJ, et al. Association of an interleukin 1α polymorphism with Alzheimer's disease. Neurology, 2000, 55: 480-483.
5. Grimaldi LM, Casadei VM, Ferri C, et al. Association of early-onset Alzheimer's disease with an interleukin-1α gene polymorphism. Ann Neurol, 2000, 47: 361-365.
6. Combarros O, Sanchez-Guerra M, Infante J, et al. Gene dose-dependent association of interleukin-1α [-899] allele 2 polymorphism with Alzheimer's disease. J Neurol, 2002, 249: 1242-1245.
7. Nicoll JA, Mrak RE, Graham DI, et al. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol, 2000, 47: 365-368.
8. Rebeck GW. Confirmation of the genetic association of interleukin-1α with early onset sporadic Alzheimer's disease. Neurosci Lett, 2000, 293: 75-77.
9. Minster RL, DeKosky ST, Ganguli M, et al. Genetic association studies of interleukin-1 (IL-1α and IL-β) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease. Ann Neurol, 2000, 48: 817-819.
10. Ki CS, Na DL, Kim DK, et al. Lack of association of the interleukin-1 alpha polymorphism with Alzheimer's disease in a Korean population. Ann Neurol, 2001, 49: 817-818.
11. Kolsch H, Ptok U, Bagli M, et al. Gene polymorphisms of interleukin-1 alpha influence the course of Alzheimer's disease. Ann Neurol, 2001, 49: 818-819.
12. Murphy GM Jr, Claassen JD, DeVoss JJ, et al. Rate of cognitive decline in AD is accelerated by the interleukin-1α-889 * 1 allele. Neurology, 2001, 56: 1595-1597.
13. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry, 1982, 140: 566-572.
14. Wu YN, Zhang JW, Zhang ZX, et al. An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population. ACTA Academiae Medicinae Sinicae, 2001, 23: 450-454.
15. Mcdowell TL, Symons JA, Ploski R, et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis Rheum, 1995, 38: 221-228.